The role of surgery for lung cancer at the end of the 2nd millenium

References: Rowinsky E.K., Ettinger D.S.: Drug development and new drugs for lung cancer. In: H.I. Pass, J.B. Mitchell, D.H. Johnson, A.T. Turrisi (eds.): Lung Cancer N principles and practices, Lippincott-Raven, Philadelphia, New York, 793-810, 1996. Bonomi P.: Non-small cell lung cancer chemotherapy. In: H.I. Pass, J.B. Mitchell, D.H. Johnson, A.T. Turrisi (eds.): Lung Cancer N principles and practices, Lippincott-Raven, Philadelphia, New York, 811-823, 1996. Albain K.S., Crowley J.J., LeBlanc M., Livingston R.B.: Survival determinants in extensive-stage non-small cell lung cancer: The Southwest Oncology Group Experience. J Clin Oncol 9, 9, 1618-1626, 1991. Somerfield MR (for ASCO): Clinical practice guide lines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 15, 8, 2996-3018, 1997